Bionovate Technologies (BIIO) 10-K 2021 FY Annual report

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Bionovate Technologies Corp. (the "Company") on Form 10-K for the period ended June 30, 2021 as filed with the Securities and Exchange Commission on or about the date hereof (the "Report"), the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: October 13, 2021

/s/ Aleksander Vucak

Aleksander Vucak

President, Chief Executive Officer,

Chief Financial Officer, Secretary and Director

(Principal Executive Officer, Principal Financial

Officer and Principal Accounting Officer)